What is Viatris's SG&A?

Viatris (VTRS) reported SG&A of $928.8M in Q1 2026.

How has Viatris's SG&A changed year-over-year?

Viatris's SG&A decreased by 2.0% year-over-year, from $948.1M to $928.8M.

What is the long-term trend for Viatris's SG&A?

Over 4 years (2021 to 2025), Viatris's SG&A has grown at a -4.3% compound annual growth rate (CAGR), from $4.53B to $3.79B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Viatris VTRS SG&A

SG&A at other companies

PfizerPFE

$2.96B-2.3%

McKessonMCK

$1.8B-9.1%

ANI PharmaceuticalsANIP

$73.66M-3.8%

CencoraCOR

$1.98B+23.6%

Aquestive Therapeutics, Inc.AQST

$10.98M-42.4%

ARS Pharmaceuticals, Inc.SPRY

$72.2M+75.7%

Other financials

Income statement

See full

Revenue$3.5B+8.1%

Gross profit$1.2B-0.3%

Operating income-$79.7M+97.2%

Net income$176.4M+106%

EPS (diluted)$0.15+106%

Balance sheet

See full

Cash & equivalents$1.8B+139%

Total debt$14.6B+1.0%

Total equity$14.7B-6.3%

Total assets$36.8B-4.3%

Cash flow

See full

Operating cash flow$388.3M-27.5%

CapEx$39.9M-6.3%

Free cash flow$348.4M-29.3%

Valuation

See full

Market cap$20.08B+84.7%

Enterprise value$32.88B+31.2%

P/S1.4×+0.6×

Profitability

See full

Gross margin34.4%-2.5pp

Operating margin1%—

Net margin-2%-1.0pp

FCF margin12.3%-1.0pp

Returns & leverage

See full

Return on equity-2%-0.9pp

Debt / equity1×+0.1×

Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viatris's SG&A?: Viatris (VTRS) reported SG&A of $928.8M in Q1 2026.
How has Viatris's SG&A changed year-over-year?: Viatris's SG&A decreased by 2.0% year-over-year, from $948.1M to $928.8M.
What is the long-term trend for Viatris's SG&A?: Over 4 years (2021 to 2025), Viatris's SG&A has grown at a -4.3% compound annual growth rate (CAGR), from $4.53B to $3.79B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.